CCL20 and hepatocellular carcinoma: revealed that tissue expression of CCL20 in clinical specimens of hepatocellular carcinoma (HCC) was related to tumor size, differentiation, recurrence, and vascular infiltration, and that high CCL20 expression was associated with worse PFS and OS in patients.